The Impact of Cytomegalovirus Infection on Ulcerative Colitis Relapse: A Multicenter Retrospective Cohort Study
Linmei Xiao,Jingjing Ma,Ruidong Chen,Jie Chen,Qiang Wang,Nana Tang,Xiaojing Zhao,Hongjie Zhang,Chunhua Jiao
DOI: https://doi.org/10.2147/jir.s479663
IF: 4.5
2024-11-27
Journal of Inflammation Research
Abstract:Linmei Xiao, 1, &ast Jingjing Ma, 2, &ast Ruidong Chen, 2, 3, &ast Jie Chen, 4 Qiang Wang, 5 Nana Tang, 2 Xiaojing Zhao, 2 Hongjie Zhang, 2 Chunhua Jiao 2 1 Department of Liver Disease, Wuxi No.5 People's Hospital Affiliated to Jiangnan University, Wuxi, People's Republic of China; 2 Department of Gastroenterology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China; 3 Department of Gastroenterology, The Second Affiliated Hospital of Soochow University, Suzhou, People's Republic of China; 4 Northern Jiangsu People's Hospital/Northern Jiangsu People's Hospital of Jiangsu Province, Yangzhou, Jiangsu Province, People's Republic of China; 5 Jiangsu Shengze Hospital, Suzhou, Jiangsu Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chunhua Jiao; Hongjie Zhang, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu Province, 210029, People's Republic of China, Tel +86 13913928581, Email ; Purpose: Cytomegalovirus (CMV) infection exacerbates intestinal inflammation in ulcerative colitis (UC) patients, yet the effect of CMV infection on UC relapse has not been fully elucidated. This study aimed to investigate the impact of CMV infection on UC relapse and identify associated risk factors. Patients and Methods: This multicenter retrospective cohort study included UC patients who visited research centers from January 2016 to December 2020. Univariate and multivariate Cox regression analyses were conducted to explore risk factors for UC relapse. Propensity score matching was used to balance the differences in the clinical characteristics between the groups. Results: A total of 298 UC patients participated in this study, including 19 with CMV colitis, 37 with CMV viremia, and 242 CMV-negative patients. The 2-year cumulative recurrence rate was higher in patients with CMV colitis than that in CMV-negative patients (84.21% vs 51.65%, p = 0.01). Univariate and multivariate Cox regression analyses confirmed that fecal calprotectin ≥ 250 μg/g, Montreal classification E3, CMV colitis, duration > 48 months, and serum albumin < 30 g/L were independent risk factors for UC relapse at 2 years, whereas the use of biologics for induction of remission was identified as an independent protective factor. Conclusion: Our study suggests that the risk of relapse increases among UC patients with CMV colitis over two years. Risk factors for UC relapse at 2 years include fecal calprotectin ≥ 250 μg/g, Montreal classification E3, CMV colitis, UC duration > 48 months, and albumin < 30 g/L, whereas the use of biologics during induction is a protective factor. Plain Language Summary: Patients with ulcerative colitis and cytomegalovirus colitis are at a higher risk of relapse over a 2-year period than those who are CMV negative. Additionally, we identified several risk factors for UC relapse at 2 years, including fecal calprotectin ≥ 250 μg/g, Montreal classification E3, CMV colitis, duration of UC ≥ 48 months, and albumin < 30 g/L, whereas the administration of biologics during remission induction contributed to reducing UC relapse. Keywords: Ulcerative colitis, cytomegalovirus colitis, relapse, risk factors Ulcerative colitis (UC) is a chronic, recurrent, and non-specific inflammatory bowel disease that often leads to adverse outcomes such as diminished intestinal function, reduced quality of life, and increased risk of colorectal cancer. 1,2 Several factors contribute to the risk of UC relapse, including young age at diagnosis, extraintestinal manifestations, and the use of glucocorticoids. 3–5 Cytomegalovirus (CMV), a member of the Herpesviridae family, is an opportunistic pathogenic virus. 6 In UC patients, CMV infection and exacerbation of intestinal inflammation are heightened owing to compromised intestinal immune barriers, glucocorticoid and immunosuppressive use, malnutrition, and extensive lesions. 7,8 Previous studies have reported CMV reactivation rates of 21–34% in acute severe UC and 32–36% in refractory UC. 9,10 Patients with UC who experience CMV infection are at an elevated risk of glucocorticoid resistance, colectomy, and mortality. 11–13 However, the relationship between CMV infection and UC relapse remains controversial topic in clinical management. Therefore, our study aimed to investigate the effect of CMV infection on UC relapse and explore the risk factors associated -Abstract Truncated-
immunology